Form 4: Vaxcyte SVP Mikhail Eydelman Reports Share Transaction
SEC Form 4 Filing
Mikhail Eydelman, SVP, General Counsel & Corporate Secretary of Vaxcyte, Inc., reports the disposition of 335 common stock shares to cover tax withholding obligations.
Summary
- On June 7, 2024, Mikhail Eydelman, SVP, General Counsel & Corporate Secretary of Vaxcyte, Inc. (PCVX), disposed of 335 shares of common stock to cover tax obligations.
- The transaction was executed at a price of $70.97 per share.
- Following the transaction, Eydelman directly owns 30,826 shares of Vaxcyte common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction related to tax obligations. Such filings are common and provide transparency into the trading activities of company executives.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a small sale of shares by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 06/07/2024 | Date of stock transaction (disposal of shares). |
| 06/10/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.